Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JOINTSTEM after High Tibial Osteotomy for Knee Osteoarthritis
NCT03000712Completed
- Sponsor
- R Bio
- Start
- Nov 2016
- Primary completion
- May 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Randomised, open-label trial of JOINTSTEM in knee osteoarthritis (OA) (2 arms), sponsored by R Bio. Primary endpoint: MRI scan at 24 months. Started Nov 2016; status: completed.
02
Drugs
JOINTSTEM
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03000712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03000712.